Trial of Sorafenib in Malignant Mesothelioma Previously Treated With Platinum-Based Chemotherapy.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Aug 2009
At a glance
- Drugs Sorafenib (Primary)
- Indications Mesothelioma
- Focus Therapeutic Use
- Acronyms SMS
- 05 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Dec 2008 New trial record.